Attention Laurel Patients:  The new Laurel office is open. The address is 7140 Contee Road, Suite 3500, Laurel, MD 20707….Attention Lanham/Largo Patients: Our new Largo office is now open and our Lanham location is closed permanently. Largo’s address is 9333 Healthcare Way Suite 4100 Largo, MD 20774.

HIPAA Alert:
Potential Data Breach : Learn More

Trial Protocol ID USOR 22136_HLX10-020-SCLC302

Trial Description

A Randomized, Double-Blind, International Multicenter, Phase III Study to Evaluate the Anti-Tumor Efficacy and Safety of HLX10 (Recombinant Humanized Anti-PD-1 Monoclonal Antibody Injection) or Placebo in Combination with Chemotherapy (Carboplatin/Cisplatin-Etoposide) and Concurrent Radiotherapy in Patients with Limited-Stage Small Cell Lung Cancer

Contact us regarding Clinical Trials at MOHRSCH@usoncology.com or call us at 877-664-7724

Investigator

  • Tejaswi R. Sastry, M.D.

Disease Types

Sponsor

  • Shanghai Henlius Biotech Co., Ltd.

ClinicalTrials.gov NCT ID

  • NCT05353257